Jobs
岗位职责:
- 参与LIMS系统的需求调研、选型、部署及配置,协调IT、QA与QC团队完成系统上线;
- 主导/支持LIMS的验证(IQ/OQ/PQ),参与编写验证文件(URS、FRS、测试脚本等),确保符合GMP要求;
- 定制化开发电子工作流(如样品管理、检验结果录入、OOS流程),优化实验室操作效率;
- 负责LIMS日常运维,包括用户权限管理、数据备份、审计追踪审核及故障排查;
- 管理系统升级/变更控制,评估变更影响并执行再验证(如适用);
- 为QC人员提供LIMS操作培训,编写SOP和用户手册;
- 确保LIMS符合数据完整性要求(如审计追踪、电子签名、防篡改),支持国内外审计(FDA/EMA/NMPA);
- 定期审核系统日志,识别并纠正潜在数据风险(如未授权操作、数据延迟录入);
- 配合完成计算机化系统周期性回顾,确保系统持续合规;
- 对接IT部门解决系统接口问题(如与ERP、CDS的集成);
- 协助QC团队处理OOS/OOT/偏差中的LIMS数据调查;
- 负责QC设备设施等日常管理,包括维护设备清单和状态,组织设备的再确认和再计量等,支持设备相关的调查等;
- 领导安排的其它相关工作。
任职要求:
- 本科及以上学历,药学、生物技术、分析化学等相关专业;
- 4年以上GMP生物制药企业的相关工作经验,1年以上LIMS运营工作经验;
- 具备较好的英语读写的能力;
- 熟悉国内外设备和系统确认相关的法规或指南,如GAMP5;
- 人员项目管理能力强,沟通表达能力强;
- 较强的独立思考和分析能力,能根据实际情况提出方案;
- 工作认真负责、考虑问题细致、有良好的团队合作精神。
Total Views
0
Apply Clicks
0
Weekly mock applicants
0
Bookmarks
0
Similar jobs
About BioNTech

BioNTech
PublicBioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
1,001-5,000
Employees
Mainz that develops immunotherapies
Headquarters
$21.7B
Valuation
Reviews
4.0
10 reviews
Work-life balance
2.5
Compensation
3.8
Culture
4.2
Career
3.5
Management
3.2
75%
Recommend to a friend
Pros
Innovative and cutting-edge projects
Great team and collaborative environment
Excellent benefits and flexible schedule
Cons
Long working hours and high workload
Fast-paced and high-pressure environment
Management and communication issues
Salary Ranges
70 data points
L2
L3
L4
L5
L6
Mid/L4
Intern
L2 · Data Scientist L2
0 reports
$53,767
total per year
Base
$21,507
Stock
$26,884
Bonus
$5,377
$37,637
$69,897
Interview experience
1 interviews
Difficulty
3.0
/ 5
Duration
14-28 weeks
Interview process
1
Application Review
2
HR Screen
3
Hiring Manager Interview
4
Panel Interview
5
Final Interview
6
Offer
Common questions
Behavioral/STAR
Technical Knowledge
Past Experience
Culture Fit
Problem Solving
News & Buzz
BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer - Oncodaily
Oncodaily
News
·
Today
BioNTech And Boehringer Trial Adds Dimension To Small Cell Lung Cancer Story - simplywall.st
simplywall.st
News
·
3d ago
Biontech prepares FDA application after strong phase II results in endometrial cancer - medwatch.com
medwatch.com
News
·
6d ago
BioNTech and DualityBio report positive data for trastuzumab pamirtecan - Clinical Trials Arena
Clinical Trials Arena
News
·
6d ago



